Craft

Alphatec Spine

Stock Price

$5.4

2024-10-29

Market Capitalization

$761.3 M

2024-10-29

Revenue

$764.2 M

FY, 2025

Alphatec Spine Summary

Company Summary

Overview
Alphatec Spine is a medical technology company focused on the design, development, and promotion of products for the surgical treatment of spinal disorders. The Company's product pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a variety of spinal disorders from degenerative disease to complex deformity and trauma.
Type
Public
Status
Active
Founded
1990
HQ
Carlsbad, CA, US | view all locations
Website
https://atecspine.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Key People

  • Patrick S. Miles

    Patrick S. Miles, Chairman and Chief Executive Officer

  • Kelli Howell

    Kelli Howell, Executive Vice President, Clinical Strategies

  • Craig Hunsaker

    Craig Hunsaker, Executive Vice President, People & Culture and General Counsel

  • Todd Koning

    Todd Koning, Chief Financial Officer

LocationsView all

2 locations detected

  • Carlsbad, CA HQ

    United States

    5818 El Camino Real

  • Carlsbad, CA

    United States

    1950 Camino Vida Roble

Alphatec Spine Financials

Summary Financials

Revenue (Q1, 2026)
$192.1M
Gross profit (Q1, 2026)
$136.5M
Net income (Q1, 2026)
($33.9M)
Cash (Q1, 2026)
$139.9M
EBIT (Q1, 2026)
($22.6M)
Enterprise value
$1.2B

Footer menu